Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM13B antisense RNA 1 (FAM13B-AS1) is a long non-coding RNA molecule transcribed from the opposite strand of the FAM13B (family with sequence similarity 13 member B) gene locus. Antisense RNAs are regulatory molecules that have sequences complementary to messenger RNAs (mRNAs) and can influence gene expression post-transcriptionally by base pairing with their corresponding sense RNAs. While several antisense lncRNAs have been linked to diverse biological roles, including modulation of gene transcription and translation, as of now there is limited published literature about the specific biological or pathological functions unique to FAM13B-AS1 itself. General characteristics of antisense RNAs include roles in gene regulation and potential involvement in diseases such as cancer. No drugs are currently known to target FAM13B-AS1 directly, and it is not established as a primary therapeutic target or biomarker.
Not applicable for any approved or experimental drug; typical mechanisms for antisense RNAs would include modulation of gene expression through RNA-RNA binding or interference with transcription or translation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM13B antisense RNA 1 (FAM13B-AS1).